Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

OrthoSpace

OrthoSpace Announces Enrollment Milestone in the InSpace Pivotal Study BY EDITOR, JANUARY 17, 2017

OrthoSpace Ltd. (“OrthoSpace” or “the Company”) announced that it has surpassed the midway point for patient enrollment in its U.S. Investigational Device Exemption (IDE) pivotal study of the InSpace biodegradable balloon system for the treatment of massive rotator cuff tears.... more

OrthoSpace Announces Publication of Positive Long-Term Follow-Up Data for InSpace System for the Treatment of Massive Rotator Cuff Tears BY EDITOR, JANUARY 4, 2017

OrthoSpace Ltd. (“OrthoSpace” or “the Company”) announced the publication of long-term follow-up data for patients enrolled in an open-label, single-arm, prospective study evaluating the use of the InSpace System for the treatment of massive rotator cuff tears (RCTs). The study,... more

OrthoSpace Announces Publication of Positive Results for the InSpace System in the Treatment of Massive Rotator Cuff Tears BY EDITOR, DECEMBER 16, 2016

OrthoSpace Ltd. ("OrthoSpace" or "Company") announced a publication in the December issue of Musculoskeletal Surgery citing positive results for their InSpace System in the surgical treatment of massive rotator cuff tears (MRCTs). Patients undergoing the InSpace procedure experienced durable improvements... more

OrthoSpace Completes Equity Financing Round BY EDITOR, DECEMBER 1, 2016

CAESAREA, Israel, Dec. 1, 2016 OrthoSpace, Ltd., a global innovative shoulder implant company, today announces that it has closed on a $7 million equity financing round. The funds will be used to support the ongoing US Investigational Device Exemption (IDE)... more

OrthoSpace Enrolls First Patients in US IDE Study BY EDITOR, JULY 6, 2015

OrthoSpace Ltd. announced the enrollment of the first three patients in its US Investigational Device Exemption (IDE) pivotal study. The study is a 184 patient randomized, single blinded control study that compares the Company's InSpace biodegradable balloon system to conventional... more

OrthoSpace Completes Significant Financing BY EDITOR, MAY 19, 2015

OrthoSpace Ltd. announced the completion of a financing transaction led by HealthpointCapital, LLC, which also includes existing investors Smith & Nephew and TriVentures. The proceeds from the transaction will facilitate the Company's continued market adoption, clinical study programs and entry... more


Complete Archive